(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -5.43%36.48B | -1.57%9.6B | 2.09%9.33B | 7.51%9.89B | -26.95%7.65B | -10.12%38.57B | -7.58%9.75B | -17.92%9.14B | -14.71%9.2B | 0.36%10.48B |
Cost of revenue | -0.52%22.31B | 12.63%5.65B | 2.91%5.59B | 11.28%6.27B | -24.29%4.81B | -12.35%22.43B | -20.18%5.01B | -19.08%5.43B | -11.56%5.63B | 1.99%6.35B |
Gross profit | -12.26%14.17B | -16.62%3.95B | 0.92%3.75B | 1.57%3.62B | -31.06%2.84B | -6.84%16.15B | 10.95%4.74B | -16.19%3.71B | -19.26%3.57B | -2.04%4.12B |
Operating expense | -11.22%12.45B | -15.55%3.11B | -4.75%3.15B | -8.29%3.16B | -15.55%3.02B | 2.59%14.02B | 8.86%3.69B | -4.51%3.31B | 2.31%3.45B | 3.83%3.58B |
Staff costs | -7.08%5.75B | ---- | ---- | ---- | ---- | 5.53%6.18B | ---- | ---- | ---- | ---- |
Selling and administrative expenses | -31.26%1.98B | ---- | ---- | ---- | ---- | -8.91%2.88B | ---- | ---- | ---- | ---- |
-Selling and marketing expense | -31.26%1.98B | ---- | ---- | ---- | ---- | -8.91%2.88B | ---- | ---- | ---- | ---- |
Research and development costs | 3.75%1.47B | ---- | ---- | ---- | ---- | 1.87%1.41B | ---- | ---- | ---- | ---- |
Depreciation and amortization | -28.91%182M | ---- | ---- | ---- | ---- | 49.71%256M | ---- | ---- | ---- | ---- |
-Depreciation | -28.91%182M | ---- | ---- | ---- | ---- | 49.71%256M | ---- | ---- | ---- | ---- |
Rent and land expenses | -11.46%417M | ---- | ---- | ---- | ---- | 10.05%471M | ---- | ---- | ---- | ---- |
Other operating expenses | -5.65%2.66B | ---- | ---- | ---- | ---- | 5.95%2.82B | ---- | ---- | ---- | ---- |
Operating profit | -19.11%1.72B | -20.36%841M | 46.93%598M | 287.39%461M | -133.33%-181M | -42.02%2.13B | 18.92%1.06B | -57.95%407M | -88.65%119M | -28.65%543M |
Net non-operating interest income (expenses) | 28.68%-92M | 41.67%-14M | -50.00%-24M | 43.48%-39M | 25.00%-15M | -46.59%-129M | 17.24%-24M | 11.11%-16M | -176.00%-69M | -25.00%-20M |
Non-operating interest income | 141.67%29M | 12.50%9M | 200.00%9M | 400.00%5M | --6M | 300.00%12M | 700.00%8M | 200.00%3M | --1M | --0 |
Non-operating interest expense | 26.92%99M | -40.91%13M | 77.78%32M | 83.33%33M | 5.00%21M | 11.43%78M | 15.79%22M | 0.00%18M | 12.50%18M | 17.65%20M |
Total other finance cost | -65.08%22M | 0.00%10M | 0.00%1M | ---- | ---- | 200.00%63M | -9.09%10M | 0.00%1M | ---- | ---- |
Net investment income | 8.14%279M | 1,592.31%220M | 21.15%-246M | -48.51%138M | -42.21%167M | 51.76%258M | -93.84%13M | -845.45%-312M | 1,024.14%268M | 1,276.19%289M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 13,400.00%135M | 0.00%1M | 131M | 0 | 3M | -98.44%1M | -93.33%1M | 0 | 0 | 0 |
Income from associates and other participating interests | ||||||||||
Special income (charges) | 75.88%-488M | 56.91%-131M | 51.24%-98M | 91.61%-127M | -2,540.00%-132M | -3,012.31%-2.02B | -1,025.93%-304M | -443.24%-201M | -1.51B | -400.00%-5M |
Less:Restructuring and mergern&acquisition | -86.62%243M | -96.37%7M | -81.82%20M | -93.26%102M | --114M | --1.82B | --193M | --110M | --1.51B | --0 |
Less:Other special charges | -127.56%-43M | -270.59%-116M | -32.53%56M | ---1M | 260.00%18M | 387.50%156M | 151.85%68M | 1,975.00%83M | --0 | 400.00%5M |
Less:Write off | 464.71%288M | 458.14%240M | 175.00%22M | ---- | ---- | 54.55%51M | --43M | --8M | ---- | ---- |
Other non-operating income (expenses) | -30.67%104M | -68.00%24M | -94.44%1M | 93.10%56M | -17.86%23M | 82.93%150M | 92.31%75M | 200.00%18M | 61.11%29M | 47.37%28M |
Income before tax | 338.73%1.65B | 15.36%939M | 442.45%363M | 141.65%486M | -116.03%-134M | -90.14%377M | -25.59%814M | -111.34%-106M | -215.54%-1.17B | 6.63%836M |
Income tax | -50.83%472M | -120.20%-41M | 29.63%245M | -1.92%256M | -96.09%12M | -24.76%960M | -52.46%203M | -30.00%189M | -16.35%261M | 14.98%307M |
Net income | 302.92%1.18B | 60.13%980M | 140.00%118M | 116.05%229M | -127.65%-146M | -122.85%-582M | -8.25%612M | -144.29%-295M | -304.44%-1.43B | 2.33%528M |
Net income continuous operations | 302.74%1.18B | 60.39%980M | 140.00%118M | 116.11%230M | -127.60%-146M | -122.89%-583M | -8.40%611M | -144.36%-295M | -304.58%-1.43B | 2.32%529M |
Noncontrolling interests | 126.46%50M | 118.84%13M | 59.46%-15M | 213.21%60M | 73.33%-8M | -9,350.00%-189M | -263.16%-69M | -23.33%-37M | -303.85%-53M | -242.86%-30M |
Net income attributable to the company | 387.79%1.13B | 42.21%967M | 151.75%133M | 112.29%169M | -124.69%-138M | -115.42%-393M | -1.02%680M | -136.98%-257M | -304.61%-1.38B | 12.93%559M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 387.79%1.13B | 42.21%967M | 151.75%133M | 112.29%169M | -124.69%-138M | -115.42%-393M | -1.02%680M | -136.98%-257M | -304.61%-1.38B | 12.93%559M |
Gross dividend payment | ||||||||||
Basic earnings per share | 395.62%60.13 | 46.15%51.46 | 152.93%7.05 | 112.31%8.76 | -124.69%-7.14 | -115.42%-20.34 | -0.90%35.21 | -137.02%-13.32 | -304.87%-71.15 | 12.75%28.92 |
Diluted earnings per share | 395.62%60.13 | 46.29%51.46 | 152.93%7.05 | 112.31%8.76 | -124.69%-7.14 | -115.42%-20.34 | -1.00%35.1759 | -137.05%-13.32 | -304.87%-71.15 | 12.75%28.92 |
Dividend per share | 0.00%25 | 0.00%25 | 0 | 0 | 0 | 0.00%25 | 0.00%25 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
No Data
No Data